17.02.2012 • News • Ashland • over-the-counter drugs • pharmaceutical ingredients

Ashland Expands PVP Production

Ashland said it is responding to strong demand for Plasdone polyvinyl pyrrolidone (PVP) by adding new low-viscosity, pharmaceutical-grade PVP capacity at its manufacturing facility in Calvert City, Ky. The company said the new capacity will further strengthen its position in the market and will enable the company to continue supporting the growing needs of its pharmaceutical customers. The additional capacity is currently being validated for pharmaceutical-grade PVP production and will be available for sale to Ashland's pharmaceutical customers in March 2012.

 

 

Company

Logo:

Ashland

500 Hercules Road Building 8145
19808 Wilmington, DE
US

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Top-Feature